Asarfi Hospital Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹313 Cr
- P/E
- 17.24
- ROE
- 18.95%
- PEG
- 0.60
- Price to sales
- 1.71
- Debt to equity
- 0.53
- 52W high / low
- ₹253 / ₹143
- Sales growth (5Y)
- 26.19%
- EBITDA margin
- 19.81%
- Net profit margin
- 9.86%
- Promoter holding
- 61.18%
- Sales (last year)
- ₹183 Cr
Incorporated in 2005, Asarfi Hospital Ltd provides primary health services & treatment and specialized super speciality health service[1]
Guidance scorecard · Q1 FY27 call
What Asarfi Hospital Ltd's management guided
and where it ranks in Healthcare Services
Healthcare Services
RevenueQ4 FY26 call
20–40%- Targeting revenue of INR 260 crores for FY27, up from INR 173.5 crores in FY26.
- Aim to scale overall bed capacity to over 500 beds by 2028 (from current 350 beds).
- Cancer hospital capacity to increase from 65 beds to 150 beds, with significant revenue growth expected from this segment.
- Revenue growth driven by bed expansion, occupancy ramp-up, ARPOB (Average Revenue Per Occupied Bed) improvement, transplant services, and management contracts.
- Expect organic and inorganic growth, including hospital acquisitions planned in FY27.
- Bone marrow transplant facility to start contributing revenue from FY28.
- Long-term plan targets INR 400 crores revenue and EBITDA margin of 23-25%.
2 more points from Asarfi Hospital Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ4 FY26 call
FlatSee what Asarfi Hospital Ltd said on margins — free account, 30 seconds.
CapexQ4 FY26 call
Planned- Healthcare Management Research Institute under construction with expected capex of INR 8 to 10 crores in the coming fiscal year.
- Additional capex of INR 2 to 3 crores planned to unlock current capacity and expand super specialty and oncology beds — total FY27 capex expected to be under INR 15 crores.
- Bed expansion plan to increase cancer hospital beds from 65 to 150, with relatively low capex of INR 2 to 3 crores due to existing infrastructure.
- Inorganic growth through hospital acquisition is underway, with technical issues being resolved and materialization expected within the financial year.
- Potential strategic management contracts and partnerships in nearby regions are in exploration as part of growth strategy.
2 more points from Asarfi Hospital Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ4 FY26 call
PlannedSee what Asarfi Hospital Ltd said on fundraising — free account, 30 seconds.
Order bookQ4 FY26 call
Ask what Asarfi Hospital Ltd said on the order book →
Full Q4 FY26 analysisRanges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Healthcare Services companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹903 Cr | — | |
| 2 | 40%+ | Flat | ₹583 Cr | 22.2 | |
| 3 | Aster DM Quality Care Ltd | 20–40% | Up 2%+ | ₹58,782 Cr | 162.9 |
| 4 | 20–40% | Up 0–2% | ₹1,730 Cr | 17.5 | |
| 5 | 20–40% | Up 0–2% | ₹580 Cr | 11.9 | |
| 6 | 20–40% | Flat | ₹1.13L Cr | 53.9 |
Sign up free to see every company in the sector ranking and track Asarfi Hospital Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services rankingFinancials of Asarfi Hospital Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Asarfi Hospital Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 20.05 | 24.04 | 30.86 | 32.89 | 35.10 | 35.66 | 44.85 | 46.06 | 45.03 |
| Expenses + | 16.04 | 20.05 | 24.06 | 25.90 | 28.64 | 28.63 | 35.94 | 35.95 | 37.17 |
| Operating Profit | 4.01 | 3.99 | 6.80 | 6.99 | 6.46 | 7.03 | 8.91 | 10.11 | 7.86 |
| OPM % | 20.00% | 16.60% | 22.03% | 21.25% | 18.40% | 19.71% | 19.87% | 21.95% | 17.46% |
| Other Income + | 1.20 | -0.41 | 1.13 | 0.89 | 3.66 | 1.42 | 0.80 | 1.50 | 0.67 |
| Interest | 0.60 | 0.76 | 0.76 | 1.18 | 1.35 | 1.22 | 1.07 | 1.25 | 0.71 |
| Depreciation | 3.25 | 3.49 | 3.18 | 3.04 | 3.23 | 2.96 | 2.88 | 2.86 | 2.74 |
| Profit before tax | 1.36 | -0.67 | 3.99 | 3.66 | 5.54 | 4.27 | 5.76 | 7.50 | 5.08 |
| Tax % | 102.94% | -76.12% | 27.07% | 25.41% | 30.87% | 25.29% | 25.17% | 27.07% | 19.49% |
| Net Profit + | -0.05 | -0.16 | 2.90 | 2.72 | 3.83 | 3.20 | 4.30 | 5.48 | 4.09 |
| EPS in Rs | -0.03 | -0.08 | 1.47 | 1.38 | 1.95 | 1.63 | 2.19 | 2.78 | 2.08 |
Financials of Asarfi Hospital Ltd
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 43 | 54 | 65 | 69 | 81 | 116 | 173 |
| Expenses + | 37 | 46 | 54 | 55 | 65 | 93 | 138 |
| Operating Profit | 6 | 8 | 11 | 14 | 16 | 24 | 36 |
| OPM % | 15% | 15% | 17% | 20% | 20% | 20% | 20% |
| Other Income + | 0 | 0 | 1 | 2 | 2 | 8 | 3 |
| Interest | 1 | 1 | 1 | 1 | 3 | 4 | 4 |
| Depreciation | 2 | 3 | 3 | 4 | 9 | 13 | 11 |
| Profit before tax | 4 | 5 | 8 | 11 | 6 | 15 | 23 |
| Tax % | 27% | 26% | 26% | 26% | 33% | 25% | 24% |
| Net Profit + | 3 | 4 | 6 | 8 | 4 | 11 | 17 |
| EPS in Rs | 21.48 | 28.83 | 46.79 | 5.53 | 2.14 | 5.58 | 8.68 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Asarfi Hospital Ltd
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 14 | 20 | 20 | 20 |
| Reserves | 12 | 16 | 21 | 27 | 51 | 62 | 79 |
| Borrowings + | 5 | 7 | 12 | 17 | 32 | 49 | 58 |
| Other Liabilities + | 9 | 13 | 28 | 34 | 52 | 34 | 38 |
| Total Liabilities | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
| Fixed Assets + | 18 | 22 | 31 | 39 | 94 | 101 | 108 |
| CWIP | 0 | 2 | 9 | 18 | 0 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 9 | 13 | 22 | 37 | 60 | 61 | 84 |
| Total Assets | 28 | 37 | 63 | 93 | 154 | 164 | 194 |
Financials of Asarfi Hospital Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 2 | 10 | 9 | 7 | 26 | -4 | 19 |
| Cash from Investing Activity + | -5 | -16 | -23 | -21 | -63 | -8 | -19 |
| Cash from Financing Activity + | 2 | 6 | 14 | 15 | 36 | 13 | 5 |
| Net Cash Flow | 0 | 0 | -0 | 1 | -1 | 1 | 5 |
| Free Cash Flow | -5 | 2 | -10 | -13 | -20 | -14 | 1 |
| CFO/OP | 62% | 142% | 104% | 73% | 162% | -3% | 69% |
Financials of Asarfi Hospital Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 14 | 30 | 90 | 109 | 125 | 114 |
| Inventory Days | 23 | 13 | 16 | 26 | 32 | 30 | 30 |
| Days Payable | 156 | 23 | 34 | 91 | 445 | 171 | 156 |
| Cash Conversion Cycle | -113 | 5 | 11 | 25 | -304 | -16 | -12 |
| Working Capital Days | -10 | -38 | -36 | 18 | 3 | 50 | 19 |
| ROCE % | 25% | 29% | 26% | 11% | 16% | 19% |
Guidance history
How Asarfi Hospital Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q4 FY26 call → | 20–40% | Flat | Planned | Planned | — |
| Q2 FY26 call → | 20–40% | Up 2%+ | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Continue your research
What Asarfi Hospital Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Rainbow Childrens Medicare Ltd (Q2 FY27)
Year-on-year (YoY) growth in revenue: 23.2% . Key investor presentation takeaways from Rainbow Childrens Medicare Ltd's Q2 FY27 investor presentation — and how
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio